CLINICAL_TRIALS
trial_result
· 2022-06-15
Clinical Trial Update: Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study [Phase 2]
Summary
Phase II single-arm prospective trial evaluating pemetrexed as salvage therapy in metastatic colorectal cancer after failure of standard chemotherapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Samsung Medical Center | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN